Fox Run Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,396
| Closed | -$276K | – | 1244 |
|
|
2025
Q1 | $276K | Sell |
15,396
-10,312
| -40% | -$185K | 0.04% | 698 |
|
|
2024
Q4 | $448K | Buy |
+25,708
| New | +$448K | 0.08% | 472 |
|
|
2024
Q3 | – | Sell |
-28,125
| Closed | -$231K | – | 1108 |
|
|
2024
Q2 | $231K | Buy |
+28,125
| New | +$231K | 0.04% | 624 |
|
|
2024
Q1 | – | Sell |
-19,678
| Closed | -$177K | – | 1066 |
|
|
2023
Q4 | $177K | Buy |
+19,678
| New | +$177K | 0.05% | 647 |
|
|
2023
Q3 | – | Sell |
-18,271
| Closed | -$281K | – | 1009 |
|
|
2023
Q2 | $281K | Buy |
+18,271
| New | +$281K | 0.08% | 473 |
|
|
2018
Q1 | – | Sell |
-17,482
| Closed | -$368K | – | 929 |
|
|
2017
Q4 | $368K | Buy |
+17,482
| New | +$368K | 0.11% | 390 |
|
|
2017
Q3 | – | Sell |
-12,700
| Closed | -$246K | – | 869 |
|
|
2017
Q2 | $246K | Buy |
+12,700
| New | +$246K | 0.09% | 484 |
|
|
2016
Q1 | – | Sell |
-16,800
| Closed | -$324K | – | 560 |
|
|
2015
Q4 | $324K | Buy |
+16,800
| New | +$324K | 0.25% | 139 |
|